Clinical Trials
4
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency
- Conditions
- Growth Hormone Deficiency in ChildrenGrowth Hormone Deficiency (GHD)Growth Hormone
- Interventions
- First Posted Date
- 2025-08-17
- Last Posted Date
- 2025-08-22
- Lead Sponsor
- Shenzhen Kexing Pharmaceutical Co., Ltd.
- Target Recruit Count
- 268
- Registration Number
- NCT07126288
- Locations
- 🇨🇳
Xiamen Maternal and Child Health Hospital, Xiamen, Fujian, China
🇨🇳Nanyang Central Hospital, Nanyang, Henan, China
🇨🇳The First Affiliated Hospital of Nanyang Medical College, Nanyang, Henan, China
Study Evaluating SHEN26 Capsule in Patients With Mild to Moderate COVID-19
- Conditions
- COVID-19
- Interventions
- Drug: SHEN26 capsuleDrug: SHEN26 placebo
- First Posted Date
- 2023-06-18
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Shenzhen Kexing Pharmaceutical Co., Ltd.
- Target Recruit Count
- 1200
- Registration Number
- NCT05908071
- Locations
- 🇨🇳
The First Affiliated Hospital Of Guangzhou Medical University, Guangzhou, Guangdong, China
Study of SHEN26 Capsule in Patients With Mild to Moderate COVID-19
- Conditions
- COVID-19
- Interventions
- Drug: SHEN26 dose 2Drug: SHEN26 dose 1Drug: SHEN26 placebo
- First Posted Date
- 2023-01-09
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Shenzhen Kexing Pharmaceutical Co., Ltd.
- Target Recruit Count
- 91
- Registration Number
- NCT05676073
- Locations
- 🇨🇳
Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, China
🇨🇳The Third People's Hospital of Shenzhen, Shenzhen, Guangdong, China
🇨🇳Shenzhen Longhua District People's Hospital, Shenzhen, Guangdong, China
A Phase I Study of SHEN26 Capsule in Healthy Participants
- Conditions
- Healthy Participants
- Interventions
- Drug: SHEN26 capsuleDrug: SHEN26 placebo
- First Posted Date
- 2022-08-17
- Last Posted Date
- 2022-12-16
- Lead Sponsor
- Shenzhen Kexing Pharmaceutical Co., Ltd.
- Target Recruit Count
- 86
- Registration Number
- NCT05504746
- Locations
- 🇨🇳
The Second Hospital of Anhui Medical University, Hefei, Anhui, China